Clinical Trial: SGLT2 Inhibitors and Renal Anemia in Japan: RWD

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07063316) titled 'SGLT2 Inhibitors and Renal Anemia in Japan: RWD' on June 24.

Brief Summary: The objectives of the study are:

1. To compare the risk and timing of anemia onset between Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitor users and non-users in patients with chronic kidney disease (CKD) from the index date to first event occurrence or the end date of each individual's follow-up.

2. To compare the following outcomes from the index date to 731 days (24 months) or the end date of each individual's follow-up:

A) Longitudinal changes in laboratory values between SGLT2 inhibitor users and non-users in patients with CKD.

B) Prescription pat...